RWE Framework: An Interactive Visual Tool to Support a Real-World Evidence Study Design

被引：0
|
作者：
Andrew D. Xia
Caroline P. Schaefer
Agota Szende
Elke Jahn
Matthew J. Hirst
机构：
[1] Mundibiopharma Limited,
[2] Covance Market Access Services,undefined
[3] Covance Market Access Services,undefined
[4] Covance Phase IV Solutions,undefined
来源：
Drugs - Real World Outcomes | 2019年 / 6卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：193 / 203
页数：10
相关论文
共 50 条
  • [1] RWE Framework: An Interactive Visual Tool to Support a Real-World Evidence Study Design
    Xia, Andrew D.
    Schaefer, Caroline P.
    Szende, Agota
    Jahn, Elke
    Hirst, Matthew J.
    [J]. DRUGS-REAL WORLD OUTCOMES, 2019, 6 (04) : 193 - 203
  • [2] UNDERSTANDING USE OF REAL-WORLD DATA (RWD) AND REAL-WORLD EVIDENCE (RWE) TO SUPPORT EFFECTIVENESS LABELING CHANGES
    Mercon, K.
    Eckert, J. C.
    Mahendraratnam, N.
    Kroetsch, A. F.
    Wosinska, M.
    McClellan, M.
    [J]. VALUE IN HEALTH, 2020, 23 : S384 - S384
  • [3] CHALLENGES TO IMPLEMENTING REAL-WORLD EVIDENCE (RWE)
    Vutova, Y.
    Dacheva, A.
    Slavchev, G.
    Djambazov, S.
    [J]. VALUE IN HEALTH, 2022, 25 (12) : S367 - S367
  • [4] REAL-WORLD EVIDENCE (RWE) TO SUPPORT REGULATORY SUBMISSIONS: LANDSCAPE ASSESSMENT & REVIEW
    Haris, G.
    Acha, V
    Liu, S.
    Burcu, M.
    [J]. VALUE IN HEALTH, 2023, 26 (06) : S213 - S213
  • [5] Real-world evidence (RWE) study to access motor vehicle accidents data: Real-world data landscaping and feasibility
    Li, Hu
    Phinney, Michael
    Khanna, Rashna
    Bragg, Sonja M.
    Clemmer, Tammy
    Oakkar, Eva
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 611 - 611
  • [6] Believability of real-world evidence (RWE) for informed regulatory decisions
    Leclerc, Jacinthe
    Brodovicz, Kimberly G.
    Chang, Stephen
    Assimon, Magdalene M.
    Urushihara, Hisashi
    Girman, Cynthia J.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 3 - 3
  • [7] AVAILABILITY OF REAL-WORLD EVIDENCE (RWE) TO SUPPORT ECONOMIC MODELLING IN PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS (PPMS)
    Brown, A.
    Curry, A.
    Cork, D.
    [J]. VALUE IN HEALTH, 2018, 21 : S210 - S210
  • [8] EVALUATION OF THE ACCEPTANCE OF REAL-WORLD EVIDENCE (RWE) IN EUNETHTA JOINT CLINICAL ASSESSMENTS (JCA) TO SUPPORT EVIDENCE FOR REIMBURSEMENT DECISIONS
    Natividad, M.
    Sestak, I
    Luna, G.
    Luijken, J.
    Gibson, B.
    Delaitre-Bonnin, C.
    Rouleau, A.
    [J]. VALUE IN HEALTH, 2023, 26 (12) : S367 - S367
  • [9] Using real-world external controls to support drug approval: An interactive framework using oncology trial and real-world data
    Hester, Laura L.
    Rivera, Donna R.
    Lund, Jennifer L.
    Golozar, Asieh
    Davis, Kourtney
    Seeger, John D.
    Sansbury, Leah
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 4 - 5
  • [10] Using real-world evidence (RWE) in regulatory decision making: A study of 6 oncology approvals with RWE included in the product label
    Zong, Jihong
    Jiao, Xiaolong
    Pan, Lucy
    Castelo, Sarah
    Campbell, Chelsey
    Lennert, Barb
    Bruno, Amanda
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
12345